Table III.

Adjusted HRs and 95% CIs for CABG compared with PCI in the matched cohort, stratified by baseline kidney function and diabetes mellitus status

	HR (95% CI)
	Diabetes	No diabetes
Death
eGFR ≥60	0.71 (0.51–0.99)	0.81 (0.61–1.09)
eGFR 45–59	0.75 (0.46–1.22)	0.67 (0.46–0.96)
eGFR <45	0.76 (0.45–1.27)	0.85 (0.58–1.23)
Acute coronary syndrome
eGFR ≥60	0.34 (0.25–0.44)	0.49 (0.38–0.63)
eGFR 45–59	0.23 (0.14–0.37)	0.29 (0.20–0.44)
eGFR <45	0.31 (0.20–0.51)	0.37 (0.22–0.61)
Repeat revascularization
eGFR ≥60	0.42 (0.32–0.55)	0.43 (0.34–0.53)
eGFR 45–59	0.41 (0.24–0.69)	0.35 (0.23–0.54)
eGFR <45	0.25 (0.13–0.45)	0.16 (0.08–0.34)